Last year, California was the first state to receive approval from the Biden administration to include sobriety payments in Medicaid, helping pave the way for contingency management (CM) programs for people with stimulant use disorder. The program was piloted as part of an extensive healthcare initiative led by Democratic Governor Gavin Newsom. This initiative aims
In a significant move to curb the rising presence of xylazine in Pennsylvania's street drug supply, state legislators have passed a bill criminalizing its illicit possession. The new legislation, known as House Bill 1661, classifies xylazine as a Schedule III drug under the Controlled Substances Act. The Pennsylvania House and Senate overwhelmingly approved the bill,
AvertD, a genetic test designed to detect which people are at heightened risk of opioid use disorder (OUD), has sparked controversy within medical circles. Despite its recent approval by the FDA, a coalition of 31 healthcare professionals and researchers is urging a reconsideration of its validity and potential implications. They say the test causes false
Tianeptine, also called gas station heroin, is an unapproved antidepressant masquerading as a dietary supplement in the U.S., posing significant risks, including addiction, severe withdrawal symptoms, and potentially fatal outcomes. Marketed as a dietary aid for energy and focus, this substance carries risks far beyond its promises. What Is Tianeptine? Tianeptine was originally an antidepressant
In a significant move aimed at combating the surge in opioid overdoses, Portland Fire & Rescue unveiled a pioneering pilot program last week. This initiative involves the distribution of medications, including buprenorphine. The program is designed to address opioid use disorder effectively by curbing cravings. Buprenorphine is less heavily regulated and, therefore, more accessible than
Seasonal Affective Disorder (SAD) is a type of depression that typically occurs at a specific time of year, usually in the fall and winter months when daylight hours are shorter. While SAD can have a significant impact on a person's mood and well-being, it is not inherently linked to addiction. However, there are some
New research into people who live with cannabis use disorder reveals that they are at 60% more danger of a stroke than non-using peers. These cardiovascular issues are not a surprise, considering most people smoke the flower when they are using marijuana. However, it gives fresh insight into something that has only begun to be
Many drug users seeking a new high search out Delta-8 and Delta-9 THC online. Delta THC is the primary psychoactive compound in cannabis. Delta-8 is another component that contributes to the high, but its effects are milder. Manufacturers claim that these drugs are derived from hemp and are typically sold in various forms at gas
Nifoxipam is a benzodiazepine that has made its way to social media and other venues that sell drugs. It's a chemical relative of flunitrazepam, a "designer" benzo drug often sold online as a research chemical. (Flunitrazepam is also called the "date rape drug" and is legally prescribed as Rohypnol.) Nifoxipam is a powerful hypnotic that
The U.S. Food and Drug Administration (FDA) has approved BRIXADI, also known as buprenorphine, for people with moderate to severe opioid use disorder. The drug is an extended-release injection for subcutaneous use (CIII), meant to be taken weekly or monthly at a healthcare provider’s office. Brixadi is a form of Medication-Assisted Treatment meant to help
